Goldman Sachs rates Vaxcyte a buy with $135 price target, highlighting vaccine platform and pneumonia candidate. Read more ...

As we are approaching winter and there is an increase in respiratory diseases, it’s also important to know about pneumococcal ...

The following is a summary of “Evaluating Sex Differences in Pneumococcal Disease Burden and Vaccination Effectiveness in ...

Pneumonia is a lung infection that annually impacts millions of people around the globe, according to the Centers for Disease ...

India's drug pricing regulator, NPPA, is increasing scrutiny of pharmaceutical companies seeking price exemptions. The NPPA is collaborating with the Indian Patent Office to evaluate applications, ...

Prioritizing disease prevention naturally requires implementing effective immunization campaigns while also fostering an ...

Immunisation helps to strengthen your child's immune system to fight diseases like polio, measles, hepatitis B, diphtheria, ...

A total of 740 patients with COVID-19 also experienced myocarditis, compared to 55 patients who had flu and 65 with RSV. The ...

The authors call for stronger vaccination systems, interventions, and catch-up campaigns in underserved populations.